Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Tech Reporter.
Press releases published on April 26, 2025
Hgh X2 Reviews 2025: Dosage ,Side Effects, Cycle (Human Growth Hormone For Muscle Growth) - HGH for Bodybuilding By Crazy Bulk
GlobeNewswire
·
April 26, 2025
New York City, April 26, 2025 (GLOBE NEWSWIRE) -- In bodybuilding, optimal muscle gain, strength, and bodybuilding are surpassed with intense training and strict dieting. For such a bodybuilder looking for a legal, natural benefit, CrazyBulk's HGH-X2 is …
Mitolyn Reviews 2025 (WARNING) Purple Peel Exploit Scientific Evidence, Complaints & What the Users Says About Mitochondrial Support!
GlobeNewswire
·
April 26, 2025
New York City, April 26, 2025 (GLOBE NEWSWIRE) -- More individuals wish to lose weight, feel more energetic, and become healthier. While most weight loss supplements offer immediate results, they can damage your long-term health. That's where Mitolyn fits …
Gluco6 Reviews (SHOCKING RESULTS) Is This Herbal Formula Control Blood Sugar Effectively or Over Hype?
GlobeNewswire
·
April 26, 2025
LOS ANGELES, April 26, 2025 (GLOBE NEWSWIRE) -- Gluco6 is a natural blood sugar support supplement emerging as a popular choice in the ever-growing market of anti-diabetic supplements. The formula targets some key aspects of glucose metabolism to stabilize …
VitaSeal Reviews (EXPERT OPINION) Does VitaSeal Really Work For Diabetes or Is It Just Hype? (Pros & Cons)
GlobeNewswire
·
April 26, 2025
MINNEAPOLIS, April 26, 2025 (GLOBE NEWSWIRE) -- VitaSeal is a natural blood sugar control formula that has been receiving much hype lately. The manufacturer claims this supplement is a combination of natural ingredients that are scientifically proven to …
A.I.S. Resources Closes Non-Brokered Private Placement
GlobeNewswire
·
April 26, 2025
VANCOUVER, British Columbia, April 25, 2025 (GLOBE NEWSWIRE) -- A.I.S. Resources Limited (TSXV: AIS, OTC- PINK: AISSF) (“AIS” or the “Company”) announces the Company has closed its non-brokered private placement of 1,232,417 units (“Units”) at a price of $ …
Skye Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 26, 2025
SAN DIEGO, April 25, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biopharmaceutical company focused on unlocking new therapeutic pathways for metabolic health, today announced that on April 23, 2025, the Board of …